Rate of opioid prescriptions written for COVID-19 long-haulers prompts addiction concerns

COVID-19 long-haulers, those who develop long-term symptoms after being infected with COVID-19, are being prescribed opioids at a rate that raises concerns about addiction, according to a recent study published in Nature.

Advertisement

About 10 percent of COVID-19 survivors develop long-term symptoms, leaving them suffering from health problems six months or longer after they’ve been diagnosed.

The study, published April 22, showed that for every 1,000 COVID-19 long-haulers treated at a Veterans Affairs facility, physicians wrote nine more opioid prescriptions than they would have otherwise. 

Ziyad Al-Aly, MD, the study’s lead author and research and development chief at VA St. Louis, told Kaiser Health News he is worried that even a small increase of inappropriate opioid prescriptions among COVID-19 long-haulers could lead to an exacerbation of the country’s opioid crisis, since there are millions of Americans currently living with long COVID-19.

The CDC released preliminary data April 14 showing more than 87,000 Americans died from drug overdoses in the 12-month period ending September 2020 — the highest annual death toll recorded since the opioid crisis started in the late 1990s.

More articles on opioids:
California seeks $50B from J&J, Teva, Endo & Allergan for role in opioid epidemic
Biden releases first-year drug policy plan
Overdose deaths jumped 29% in 2020, CDC says

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.